MSPRZ
MSPRZ
MSP Recovery, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $198K ▼ | $123.7M ▼ | $-167.81M ▼ | -84.75K% ▼ | $-132.71 ▼ | $3.77M ▼ |
| Q2-2025 | $536K ▼ | $125.27M ▼ | $-143.18M ▼ | -26.71K% ▼ | $-29.15 ▲ | $120.37M ▲ |
| Q1-2025 | $837K ▼ | $127.03M ▼ | $-121.6M ▲ | -14.53K% ▼ | $-33.7 ▲ | $1.5M ▲ |
| Q4-2024 | $8.24M ▲ | $881.38M ▲ | $-286.63M ▼ | -3.48K% ▼ | $-161.42 ▼ | $-743.46M ▼ |
| Q3-2024 | $3.67M | $131.87M | $-29.85M | -813.71% | $-31.5 | $37.35M |
What's going well?
The only slight positive is that operating losses narrowed a bit. If the company can cut costs further or find new revenue, there may be a path to stabilization.
What's concerning?
Revenue collapsed, losses grew, and the company massively diluted shareholders. Interest expense and other costs are overwhelming, and the business is losing money on every sale.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.82M ▼ | $1.55B ▼ | $2.4B ▲ | $-563.84M ▼ |
| Q2-2025 | $3.99M ▼ | $1.67B ▼ | $2.28B ▲ | $-207.16M ▼ |
| Q1-2025 | $9.07M ▼ | $1.8B ▼ | $2.16B ▲ | $-60.82M ▼ |
| Q4-2024 | $12.33M ▲ | $1.92B ▼ | $2.05B ▲ | $100.58M ▼ |
| Q3-2024 | $4.75M | $2.79B | $1.94B | $300.35M |
What's financially strong about this company?
The only slight positive is that total debt fell by $100 million this quarter. There are no large lease or accrued expense surprises.
What are the financial risks or weaknesses?
The company has almost no cash, massive debt, and owes far more than it owns. Most assets are intangible and could lose value quickly. Negative equity and falling cash make survival very unlikely without urgent new funding.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-124.68M ▲ | $3.7M ▲ | $108.83M ▲ | $1.24M ▼ | $-2.17M ▲ | $3.86M ▲ |
| Q2-2025 | $-241.78M ▼ | $-8.46M ▼ | $-108.83M ▼ | $3.38M ▼ | $-5.08M ▼ | $-8.46M ▼ |
| Q1-2025 | $-121.6M ▲ | $-7.19M ▼ | $-163K ▲ | $4.1M ▼ | $-3.25M ▼ | $-7.36M ▼ |
| Q4-2024 | $-796.74M ▼ | $1.73M ▲ | $-364K ▲ | $6.22M ▼ | $7.58M ▲ | $1.37M ▲ |
| Q3-2024 | $-190.38M | $-6.69M | $-2.02M | $6.34M | $-2.37M | $-8.71M |
What's strong about this company's cash flow?
Operating cash flow and free cash flow both turned positive this quarter, a big improvement from last quarter. The company is spending very little on capital investments, keeping cash needs low.
What are the cash flow concerns?
Cash balance is very low at $1.8 million, and positive cash flow was mostly due to delaying payments to suppliers. If this can't continue, cash could run out quickly.
Q3 2022 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at MSP Recovery, Inc.'s financial evolution and strategic trajectory over the past five years.
Key positives include very high gross margins, which imply that each dollar of revenue has strong underlying economics before overhead. The company has demonstrated the ability to generate bursts of strong revenue growth, suggesting market interest in its solutions. Strategically, it benefits from differentiated technology, a large and growing claims portfolio, and notable partnerships, particularly in advanced data analytics. Its LifeWallet ecosystem and blockchain initiatives show a willingness to innovate and potentially reshape how healthcare claims and records are handled.
Major risks are concentrated around financial sustainability and execution. Operating and net losses have grown substantially, and cash flows from operations are materially negative, indicating that the business is not currently self‑funding. The balance sheet is highly leveraged, with significant debt and weak liquidity metrics, and accumulated losses have eroded equity. The company itself has signaled doubt about its ability to continue without additional funding. Beyond financials, it is exposed to legal, regulatory, and competitive risks inherent in litigating and monetizing complex insurance claims against large, well‑resourced counterparties.
The outlook is highly uncertain and depends on a few critical swings: whether MSP Recovery can convert its innovative technology and growing claims portfolio into reliable, sizable recoveries, and whether it can right‑size its cost structure and balance sheet before financial pressures intensify. If the platform gains broad adoption and legal outcomes are favorable, the business model could become much more attractive. If not, persistent losses, heavy leverage, and liquidity strain may continue to weigh on the company’s prospects. In the near term, the focus is likely to remain on securing funding, improving operational discipline, and demonstrating that its technology can deliver meaningful, repeatable economic returns.
About MSP Recovery, Inc.
https://www.msprecovery.comMSP Recovery, Inc. provides compliance solutions for the healthcare industry in the United States. The company offers Medicare, Medicaid, commercial, and secondary payer reimbursement recovery services.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $198K ▼ | $123.7M ▼ | $-167.81M ▼ | -84.75K% ▼ | $-132.71 ▼ | $3.77M ▼ |
| Q2-2025 | $536K ▼ | $125.27M ▼ | $-143.18M ▼ | -26.71K% ▼ | $-29.15 ▲ | $120.37M ▲ |
| Q1-2025 | $837K ▼ | $127.03M ▼ | $-121.6M ▲ | -14.53K% ▼ | $-33.7 ▲ | $1.5M ▲ |
| Q4-2024 | $8.24M ▲ | $881.38M ▲ | $-286.63M ▼ | -3.48K% ▼ | $-161.42 ▼ | $-743.46M ▼ |
| Q3-2024 | $3.67M | $131.87M | $-29.85M | -813.71% | $-31.5 | $37.35M |
What's going well?
The only slight positive is that operating losses narrowed a bit. If the company can cut costs further or find new revenue, there may be a path to stabilization.
What's concerning?
Revenue collapsed, losses grew, and the company massively diluted shareholders. Interest expense and other costs are overwhelming, and the business is losing money on every sale.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.82M ▼ | $1.55B ▼ | $2.4B ▲ | $-563.84M ▼ |
| Q2-2025 | $3.99M ▼ | $1.67B ▼ | $2.28B ▲ | $-207.16M ▼ |
| Q1-2025 | $9.07M ▼ | $1.8B ▼ | $2.16B ▲ | $-60.82M ▼ |
| Q4-2024 | $12.33M ▲ | $1.92B ▼ | $2.05B ▲ | $100.58M ▼ |
| Q3-2024 | $4.75M | $2.79B | $1.94B | $300.35M |
What's financially strong about this company?
The only slight positive is that total debt fell by $100 million this quarter. There are no large lease or accrued expense surprises.
What are the financial risks or weaknesses?
The company has almost no cash, massive debt, and owes far more than it owns. Most assets are intangible and could lose value quickly. Negative equity and falling cash make survival very unlikely without urgent new funding.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-124.68M ▲ | $3.7M ▲ | $108.83M ▲ | $1.24M ▼ | $-2.17M ▲ | $3.86M ▲ |
| Q2-2025 | $-241.78M ▼ | $-8.46M ▼ | $-108.83M ▼ | $3.38M ▼ | $-5.08M ▼ | $-8.46M ▼ |
| Q1-2025 | $-121.6M ▲ | $-7.19M ▼ | $-163K ▲ | $4.1M ▼ | $-3.25M ▼ | $-7.36M ▼ |
| Q4-2024 | $-796.74M ▼ | $1.73M ▲ | $-364K ▲ | $6.22M ▼ | $7.58M ▲ | $1.37M ▲ |
| Q3-2024 | $-190.38M | $-6.69M | $-2.02M | $6.34M | $-2.37M | $-8.71M |
What's strong about this company's cash flow?
Operating cash flow and free cash flow both turned positive this quarter, a big improvement from last quarter. The company is spending very little on capital investments, keeping cash needs low.
What are the cash flow concerns?
Cash balance is very low at $1.8 million, and positive cash flow was mostly due to delaying payments to suppliers. If this can't continue, cash could run out quickly.
Q3 2022 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at MSP Recovery, Inc.'s financial evolution and strategic trajectory over the past five years.
Key positives include very high gross margins, which imply that each dollar of revenue has strong underlying economics before overhead. The company has demonstrated the ability to generate bursts of strong revenue growth, suggesting market interest in its solutions. Strategically, it benefits from differentiated technology, a large and growing claims portfolio, and notable partnerships, particularly in advanced data analytics. Its LifeWallet ecosystem and blockchain initiatives show a willingness to innovate and potentially reshape how healthcare claims and records are handled.
Major risks are concentrated around financial sustainability and execution. Operating and net losses have grown substantially, and cash flows from operations are materially negative, indicating that the business is not currently self‑funding. The balance sheet is highly leveraged, with significant debt and weak liquidity metrics, and accumulated losses have eroded equity. The company itself has signaled doubt about its ability to continue without additional funding. Beyond financials, it is exposed to legal, regulatory, and competitive risks inherent in litigating and monetizing complex insurance claims against large, well‑resourced counterparties.
The outlook is highly uncertain and depends on a few critical swings: whether MSP Recovery can convert its innovative technology and growing claims portfolio into reliable, sizable recoveries, and whether it can right‑size its cost structure and balance sheet before financial pressures intensify. If the platform gains broad adoption and legal outcomes are favorable, the business model could become much more attractive. If not, persistent losses, heavy leverage, and liquidity strain may continue to weigh on the company’s prospects. In the near term, the focus is likely to remain on securing funding, improving operational discipline, and demonstrating that its technology can deliver meaningful, repeatable economic returns.

CEO
John H. Ruiz

